Guaifenesin/Pseudoephedrine Hydrochloride

愈创甘油醚/盐酸伪麻黄碱

Report date: 2022/09/08 18:11:24

Base Information

Drug NameGuaifenesin/Pseudoephedrine Hydrochloride
Drug Alias Name愈创木酚甘油醚/盐酸伪麻黄碱
ClassificationSmall molecules
Mechanisms of ActionAlpha adrenergic receptor agonists
TargetsAlpha adrenergic receptor
Therapy Area/IndicationsCoughNasal Obstruction
Global Approved IndicationsCoughNasal Obstruction
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2004/06/22
Country/TerritoryUnited StatesMainland China
CombinationsYes GuaifenesinPseudoephedrine Hydrochloride
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesReckitt Benckiser Group Plc
China Registration ClassN/A

Develop Information

Active CompaniesReckitt Benckiser LlcChifeng Mysun Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsCoughNasal Obstruction
Inactive IndicationsN/A

Other Information

ATC CodeR01BA52
Related LinksN/A